TAK1 integrates the NLRP1 inflammasome into the innate immune response to double-stranded RNA
Innate immune recognition of double-stranded RNA (dsRNA) by germline-encoded receptors initiates antiviral defenses, including type I interferon (IFN) production. The inflammasome-forming sensor NLRP1 binds and is activated by dsRNA in a mitogen-activated protein kinase (MAPK) p38-dependent manner. How dsRNA initiates these events to induce NLRP1 inflammasome activation is unclear. Here we demonstrate that both exogenous and cellular dsRNA triggers NLRP1 inflammasome activation downstream of RIG-I/MDA5-MAVS and/or TLR3-TRIF signaling but is independent of type I IFN. In immortalized and primary human keratinocytes, we find that NLRP1 inflammasome activation by dsRNA, including during viral infection, requires the MAPK kinase kinase TAK1. Mechanistically, TAK1-dependent phosphorylation of the NLRP1 N-terminal disordered region is necessary and sufficient for inflammasome activation. Collectively, we reveal TAK1 as a novel activator of the NLRP1 inflammasome, functioning as a critical signaling hub linking NLRP1 to inflammatory responses in the context of viral infection and autoimmunity.
Authors
- Tiffany M. Lucas
- Miles R. Corley (ORCID: https://orcid.org/0009-0001-1134-9617)
- Patrick S. Mitchell (ORCID: https://orcid.org/0000-0001-8375-9060)
- Marisa A. Yonemitsu (ORCID: https://orcid.org/0000-0003-3290-4306)
- Amandine Chantharath
- Ayumu Hyodo
- Hunter C Toyoda
Institutions
- Université Claude Bernard Lyon 1 (FR)
- École Normale Supérieure de Lyon (FR)
- Centre National de la Recherche Scientifique (FR)
- Howard Hughes Medical Institute (US)
- Inserm (FR)
- University of Washington (US)
- Centre International de Recherche en Infectiologie (FR)
- The University of Tokyo (JP)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-01-25
- DOI
- https://doi.org/10.64898/2026.01.23.701331
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Pennsylvania
- National Institutes of Health
- Penn Skin Biology and Diseases Resource-based Center, University of Pennsylvania
- Medical Research Council